Quick answer: You automate prior authorizations for neurology procedures by triggering the request the moment an order is placed, letting AI verify eligibility, match the payer's medical-necessity criteria, assemble the documentation, and submit and track it electronically, by portal, or by fax. The workflow handles the procedure-specific details that cause neurology denials — step-therapy proof for drugs, unit and wastage documentation for Botox, NDC and J-codes for infusions, and medical-necessity narratives for imaging. Your staff steps in only for peer-to-peer reviews and judgment calls.
Where neurology prior authorization volume actually comes from
Before automating anything, it helps to name the procedures that generate the work. In a neurology practice, prior authorization clusters around a predictable set of high-documentation services, and each one fails in its own way.
Advanced imaging — brain and spine MRI, PET — is the everyday volume driver, and most denials trace to thin medical-necessity documentation. Electrodiagnostics (EMG/NCS, EEG) carry payer-specific necessity rules and component-coding traps. Botox for chronic migraine and dystonia needs unit and wastage detail that's easy to fumble. Infusions require exact drug and J-code data. And the disease-modifying and high-cost drugs — CGRP biologics, MS therapies, anti-seizure regimens — are the hardest, because step therapy drives most of their denials.
This concentration is why automation pays off in neurology specifically. The 2024 AMA prior authorization survey found practices complete an average of 39 prior authorizations per physician per week, consuming roughly 13 hours of combined staff and physician time. In neurology, where the procedure mix is auth-heavy, that number runs high — and it's concentrated on a handful of repeatable workflows that automation handles well.
How does the automated prior authorization workflow actually run?
The automated workflow runs as a chain of steps that fire from the order, with your staff watching the exceptions rather than driving each request. Here's the sequence.
- Trigger at scheduling. When a provider orders an MRI, an EMG, a Botox injection, or an infusion, the system checks it against payer rules and flags that an auth is required — before the patient is scheduled, not after.
- Eligibility check. The agent confirms active coverage, benefit design, and whether the service falls under the medical or pharmacy benefit, so the auth isn't built on stale insurance data.
- Clinical-criteria matching. It pulls the chart data the payer wants and maps it against that specific plan's medical-necessity policy — including step-therapy requirements for drugs.
- Document assembly. It builds the request package: codes, demographics, provider NPIs, supporting notes, and prior-trial history where step therapy applies.
- Submission. It sends the request in the payer's accepted format — electronic transaction, portal, or fax.
- Status follow-up. It polls the payer on a schedule and writes status back into the EHR work queue, so no one logs into a portal to ask "any movement?"
The follow-up step is where manual processes leak. Submission is a one-time task; status-chasing is recurring, and it's where neurology auths slip through cracks and become denied claims or rescheduled patients.
How do you handle the procedure-specific gotchas?
Generic prior authorization tools stumble on neurology because each procedure has its own failure mode. Automation earns its keep by handling these details, not just the happy path.
- Imaging medical necessity. For MRI and PET, the agent assembles the clinical narrative and prior-conservative-treatment history that payers demand, closing the documentation gap that causes most imaging denials.
- EMG/NCS criteria and coding. It verifies the payer's necessity criteria before the study and pre-populates the correct component codes, avoiding the mismatches that trigger rejections.
- Botox units and wastage. It tracks the authorization window so it doesn't expire, and captures unit and wastage detail so a covered injection doesn't become a write-off.
- Infusion NDC and J-codes. It assembles the exact drug, NDC, and J-code data the claim needs, and confirms whether the drug sits under the medical or pharmacy benefit.
- Drug step therapy. For CGRP and MS drugs, it pulls the record of prior medications tried and failed — the single most common reason these auths get denied on first pass.
Getting these details right is the difference between a first-pass approval and a month-long appeal cycle. According to the 2024 CAQH Index, only about 35% of medical prior authorizations are fully electronic, so most of this still runs through portals and fax — which is exactly where a generic tool that only handles electronic transactions leaves your neurology volume stranded.
How does the automation connect to your EHR and scheduling?
Automation works best when it lives inside the systems your team already uses, not beside them. The agent connects to the EHR through HL7 or FHIR interfaces, reads orders and clinical data directly from the chart, and writes auth numbers and statuses back into the work queue.
That write-back is the part that changes the day-to-day. Instead of a coordinator opening five payer portals to check status, the EHR queue shows current state automatically. Approvals land on the encounter so scheduling and billing can proceed; denials route to a person with the reason attached.
This is where a platform like Honey Health fits the neurology workflow. Its Prior Authorization agent runs alongside its Eligibility agent, so an auth starts from a benefits check that's already run rather than from scratch — and both write back into the EHR your front desk and billers already live in. The point isn't a new dashboard to monitor; it's fewer rows in the queue your team already watches.
What still needs a human in the loop?
Automation handles the routine majority, but a few categories of neurology PA work stay with people — and an honest workflow plans for them rather than pretending they don't exist.
Peer-to-peer reviews need a neurologist on the phone with the payer's medical director; the agent's job is to surface the request early and attach the case file. Medical-necessity judgment calls on borderline imaging or off-label drug use stay with clinicians. And appeals strategy on high-dollar denials benefits from a coordinator who knows which fights are worth having.
The realistic end state is a smaller, sharper PA function. Your coordinators stop keying chart data into portals and start working the exceptions — peer-to-peers, appeals, and ambiguous cases — while the routine imaging and refill auths flow through on their own. That shift in what your staff spends time on is the real win.
How do you roll this out without disrupting the practice?
A clean rollout protects the workflow your team already trusts. Two practices separate the deployments that stick from the ones that stall.
First, run a parallel period. Let the automation process live neurology volume alongside your manual process for a few weeks, and audit the agreement rate before you trust it with auto-submission. You want to see it handle your actual MRI and CGRP auths, not a vendor's clean demo data.
Second, name an exception owner up front. A review queue someone owns gets worked same-day; an orphaned queue becomes the new backlog. Decide who handles the flagged cases before go-live. The CMS Interoperability and Prior Authorization Final Rule is pushing major payers to stand up FHIR-based PA APIs, with key provisions effective in 2027 — so build your workflow now in a way that can ride those rails as they come online.
Frequently asked questions
How do you automate prior authorizations for neurology procedures?
You automate them by triggering the auth at order entry, verifying eligibility, matching the payer's medical-necessity criteria, assembling the documentation, and submitting and tracking the request electronically, by portal, or by fax. The system handles procedure-specific details — imaging necessity, EMG coding, Botox units, infusion J-codes, and drug step therapy — while routing exceptions to staff.
Can you automate Botox and infusion prior authorizations specifically?
Yes. For Botox, automation tracks the authorization window and captures unit and wastage documentation so a covered injection doesn't expire or get miscoded. For infusions, it assembles the exact NDC and J-code data the claim needs and confirms whether the drug falls under the medical or pharmacy benefit before submission.
How does automation reduce neurology drug denials?
Most CGRP and MS-drug denials come from incomplete step-therapy documentation. Automation pulls the patient's prior tried-and-failed medications and clinical history from the EHR, maps them to the payer's step-therapy policy, and flags missing elements before submission — closing the gap that causes first-pass denials.
Does the automation integrate with our scheduling and EHR?
It connects through HL7 or FHIR, reads orders and clinical data from the chart, and writes auth numbers and statuses back into the work queue your team already uses. Auths trigger at scheduling, and approvals land on the encounter so booking and billing proceed without manual lookups.
How long does it take to set up neurology prior authorization automation?
Most implementations land in a 30–60 day range depending on your EHR and integration method, plus a parallel-validation period where the system runs alongside your manual process. Confirm the timeline for your specific EHR and define who owns the exception queue before going live.
Will automation replace our prior authorization coordinators?
Usually not. It removes the repetitive data-gathering and status-chasing, so coordinators shift to peer-to-peer scheduling, appeals, and judgment calls. Most neurology practices redeploy those recovered hours rather than cut staff, keeping the experienced coordinators whose payer knowledge the software can't replicate.
